Curcumin-encapsulating nanogels as an effective anticancer formulation for intracellular uptake

Molecular and Cellular Pharmacology

Volumn 7, Issue 3, 2015, Pages 25-40

  Reeves, Anna ^a   Vinogradov, Serguei V ^b   Morrissey, Phil ^c   Chernin, Mitchell ^a   Ahmed, Mansoor M ^d  

^a BUCKNELL UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Amnis Corporation   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anticancer drugs and breast cancer cells; Curcumin; Nanogels

Indexed keywords

CELL SURFACE RECEPTOR; CURCUMIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG RELEASE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC50; NANOENCAPSULATION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; SIZE EXCLUSION CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84961620656     PISSN: None     EISSN: 19381247     Source Type: Journal    
DOI: 10.4255/mcpharmacol.15.04     Document Type: Article

References (48)

1. Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 2015;35:645-51.
2. Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed M, Alharbi SA, Tan BK, Kumar AP, Sethi G. The multifaceted role of curcumin in cancer prevention and treatment. Molecules 2015;20:2728-69.
3. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011;10:1-19.
4. Basnet P, Skalko-Basnet N. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011;16:4567-98.
5. Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Molecular nutrition & food research 2013;57:1510-28.
6. Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors 2013;39:69-77.
7. Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12:332-47.
8. Chen J, Wang F, Chen W. Modulation of apoptosisrelated cell signalling pathways by curcumin as a strategy to inhibit tumor progression. Mol Biol Rep 2014;41:4583-94.
9. Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Herbal antioxidant in clinical practice: A review. Asian Pacific journal of tropical biomedicine 2014;4:78-84.
10. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: From kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
11. Bandyopadhyay D. Farmer to pharmacist: Curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer. Frontiers in chemistry 2014;2
12. Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U. miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via downregulation of the inflammatory cytokines CXCL1 and-2. Molecular oncology 2014;8:581-95.
13. Dorai T, Diouri J, O'Shea O, Doty SB. Curcumin inhibits prostate cancer bone metastasis by up-regulating bone morphogenic protein-7 in vivo. Journal of cancer therapy 2014;5:369.
14. Xu X, Qin J, Liu W. Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/akt signaling pathway. Gene 2014;546:226-32.
15. Sordillo PP, Helson L. Curcumin and cancer stem cells: Curcumin has asymmetrical effects on cancer and normal stem cells. Anticancer Res 2015 Feb;35:599-614.
16. Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv 2014;32:1053-64.
17. Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3, 5-bis (2-pyridinylmethylidene)-4-piperidone (EF31): Antiinflammatory and anti-cancer properties. Int Immunopharmacol 2012;12:368-77.
18. Aggarwal BB, Heber D. 19 spices and dietary supplements with anti-inflammatory activity. Immunonutrition: Interactions of Diet, Genetics, and Inflammation 2014:317.
19. Vinogradov S, Wei X. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine 2012;7:597-615.
20. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008; 269:199-225.
21. Bimonte S, Barbieri A, Palma G, Luciano A, Rea D, Arra C. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. Biomed Res Int 2013:810423
22. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004;23:1599-607.
23. Girdhani S, Ahmed MM, Mishra KP. Enhancement of gamma radiation-induced cytotoxicity of breast cancer cells by curcumin. Molecular and Cellular Pharmacology 2009;1:208-17.
24. Gupta S, Goyal P, Ahmed MM. Novel translational research concepts and strategies in radiation oncology. Molecular and Cellular Pharmacology 2009;1:103-11.
25. Patel VN, Gupta S, Shareef MM, Ahmed MM. Contemporary radiation countermeasure (review paper). Def Sci J 2011;61:138-45.
26. Lee W, Loo C, Bebawy M, Luk F, Mason RS, Rohanizadeh R. Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Current neuropharmacology 2013;11:338.
27. McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, Xhillari D, Jaeger R, Stanwood G, Chekmenev E, Tooyama I. Inhalable curcumin: Offering the potential for translation to imaging and treatment of alzheimer's disease. J Alzheimer's Dis 2015;44:283-95.
28. Steigerwalt R, Nebbioso M, Appendino G, Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone M. Meriva, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med 2012;54:11.
29. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004;304:600-2.
30. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008;14:4491-9.
31. Lee W, Loo C, Young PM, Traini D, Mason RS, Rohanizadeh R. Recent advances in curcumin nanoformulation for cancer therapy. Expert opinion on drug delivery 2014;11:1183-201.
32. Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010;81:680-9.
33. Niu Y, Ke D, Yang Q, Wang X, Chen Z, An X, Shen W. Temperature-dependent stability and DPPH scavenging activity of liposomal curcumin at pH 7.0. Food Chem 2012;135:1377-82.
34. Lee W, Loo C, Young PM, Traini D, Mason RS, Rohanizadeh R. Recent advances in curcumin nanoformulation for cancer therapy. Expert opinion on drug delivery 2014;11:1183-201.
35. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumorselective macromolecular drug targeting. Adv Enzyme Regul 2001;41:189-207.
36. Wei X, Senanayake TH, Warren G, Vinogradov SV. Hyaluronic acid-based nanogel–drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjug Chem 2013;24:658-68.
37. Kohli E, Han H, Zeman AD, Vinogradov SV. Formulations of biodegradable nanogel carriers with 5′- triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity. J Controlled Release 2007;121:19-27.
38. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities. Angewandte Chemie International Edition 2009;48:5418-29.
39. Vinogradov SV, Kohli E, Zeman AD. Comparison of nanogel drug carriers and their formulations with nucleoside 5′-triphosphates. Pharm Res 2006;23:920-30.
40. Vinogradov SV, Batrakova EV, Kabanov AV. Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 2004;15:50-60.
41. Zhang H, Vinogradov SV. Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells. J Controlled Release 2010;143:359-66.
42. Xing JZ, Zhu L, Jackson JA, Gabos S, Sun X, Wang X, Xu X. Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol 2005;18:154-61.
43. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 2005;5-12.
44. Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol 2008;32:1119-23.
45. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310-6.
46. Meng H, Liong M, Xia T, Li Z, Ji Z, Zink JI, Nel AE. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS nano 2010;4:4539-50.
47. Vinogradov S, Wei X. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine 2012;7:597-615.
48. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacological Research 2010;62:90-9.